↓ Skip to main content

Stem Cells: Biology and Engineering

Overview of attention for book
Attention for Chapter 67: Stem Cell Therapy for Fanconi Anemia
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Stem Cell Therapy for Fanconi Anemia
Chapter number 67
Book title
Advances in Experimental Medicine and Biology
Published in
Advances in experimental medicine and biology, July 2017
DOI 10.1007/5584_2017_67
Pubmed ID
Book ISBNs
978-3-31-977481-7, 978-3-31-977482-4
Authors

Zhang, Qing-Shuo, Qing-Shuo Zhang

Abstract

Stem cell therapy is the administration of stem cells to a patient to treat or prevent a disease. Since stem cells possess the long-term self-renewal capacity and provide daughter cells that differentiate into the specialized cells of each tissue, stem cell therapy will theoretically improve the disease condition for the lifetime of the patient. As the most widely used stem cell therapy, bone marrow transplantation is the treatment of choice for many kinds of blood disorders, including anemias, leukemias, lymphomas, and rare immunodeficiency diseases. For the fatal genetic blood disorder Fanconi anemia, allogeneic bone marrow transplantation has remained the only curative treatment. But the recent advances in stem cell and gene therapy fields may provide promising opportunities for an alternative or even better management of Fanconi anemia. Many of these new ideas and opportunities are also useful for treating other blood diseases that affect hematopoietic stem cells, such as sickle cell anemia, severe combined immunodeficiencies, and beta-thalassemias. In this chapter, these advances along with their challenges and limitations will be thoroughly discussed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 27%
Student > Ph. D. Student 3 14%
Student > Doctoral Student 2 9%
Unspecified 1 5%
Other 1 5%
Other 4 18%
Unknown 5 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 36%
Medicine and Dentistry 2 9%
Agricultural and Biological Sciences 2 9%
Unspecified 1 5%
Nursing and Health Professions 1 5%
Other 2 9%
Unknown 6 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2017.
All research outputs
#14,816,244
of 22,986,950 outputs
Outputs from Advances in experimental medicine and biology
#2,254
of 4,959 outputs
Outputs of similar age
#184,066
of 312,623 outputs
Outputs of similar age from Advances in experimental medicine and biology
#29
of 84 outputs
Altmetric has tracked 22,986,950 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,959 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 312,623 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.